

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * drug transmembrane transport (GO:0006855) | 9.30927775 |
| 2 | phosphate ion transport (GO:0006817) | 8.38378273 |
| 3 | lysine catabolic process (GO:0006554) | 8.29988541 |
| 4 | lysine metabolic process (GO:0006553) | 8.29988541 |
| 5 | * drug transport (GO:0015893) | 8.01002442 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.46712673 |
| 7 | drug catabolic process (GO:0042737) | 7.27344479 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.16275348 |
| 9 | * organic cation transport (GO:0015695) | 6.99125103 |
| 10 | phosphate ion transmembrane transport (GO:0035435) | 6.93751553 |
| 11 | cysteine metabolic process (GO:0006534) | 6.91256902 |
| 12 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 6.75096959 |
| 13 | nephron tubule formation (GO:0072079) | 6.40766623 |
| 14 | tricarboxylic acid metabolic process (GO:0072350) | 6.22771186 |
| 15 | nonribosomal peptide biosynthetic process (GO:0019184) | 6.19738205 |
| 16 | response to mercury ion (GO:0046689) | 6.18038882 |
| 17 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.88108248 |
| 18 | collecting duct development (GO:0072044) | 5.77290358 |
| 19 | excretion (GO:0007588) | 5.74372086 |
| 20 | short-chain fatty acid metabolic process (GO:0046459) | 5.63372687 |
| 21 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 5.62616084 |
| 22 | aspartate family amino acid catabolic process (GO:0009068) | 5.60733109 |
| 23 | vitamin D metabolic process (GO:0042359) | 5.59736890 |
| 24 | glutathione biosynthetic process (GO:0006750) | 5.58245312 |
| 25 | * quaternary ammonium group transport (GO:0015697) | 5.50309493 |
| 26 | toxin transport (GO:1901998) | 5.45021389 |
| 27 | branched-chain amino acid metabolic process (GO:0009081) | 5.42170475 |
| 28 | renal absorption (GO:0070293) | 5.40534077 |
| 29 | negative regulation of metanephros development (GO:0072217) | 5.38102046 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.30579313 |
| 31 | trivalent inorganic anion homeostasis (GO:0072506) | 5.15656976 |
| 32 | phosphate ion homeostasis (GO:0055062) | 5.15656976 |
| 33 | amino-acid betaine transport (GO:0015838) | 5.08323701 |
| 34 | carnitine transport (GO:0015879) | 5.08323701 |
| 35 | metanephric nephron tubule development (GO:0072234) | 5.06124879 |
| 36 | metanephric tubule development (GO:0072170) | 5.06124879 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.03766661 |
| 38 | L-phenylalanine metabolic process (GO:0006558) | 5.03766661 |
| 39 | polyol transport (GO:0015791) | 4.99461541 |
| 40 | valine metabolic process (GO:0006573) | 4.96418808 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.95073653 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 4.95073653 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.87623866 |
| 44 | cellular modified amino acid catabolic process (GO:0042219) | 4.83818679 |
| 45 | proline metabolic process (GO:0006560) | 4.81752114 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 4.81136485 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 4.79296399 |
| 48 | glycoside metabolic process (GO:0016137) | 4.78567028 |
| 49 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.78216579 |
| 50 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.78188046 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.74264354 |
| 52 | meiotic chromosome segregation (GO:0045132) | 4.70486044 |
| 53 | metanephric nephron epithelium development (GO:0072243) | 4.65438146 |
| 54 | modified amino acid transport (GO:0072337) | 4.63941160 |
| 55 | tryptophan catabolic process (GO:0006569) | 4.61630139 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 4.61630139 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 4.61630139 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.53621379 |
| 59 | actin filament depolymerization (GO:0030042) | 4.51782831 |
| 60 | 2-oxoglutarate metabolic process (GO:0006103) | 4.48068148 |
| 61 | peptide biosynthetic process (GO:0043043) | 4.47754234 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 4.45794616 |
| 63 | tryptophan metabolic process (GO:0006568) | 4.40856887 |
| 64 | branched-chain amino acid catabolic process (GO:0009083) | 4.34252744 |
| 65 | tooth mineralization (GO:0034505) | 4.31960542 |
| 66 | fructose metabolic process (GO:0006000) | 4.30301113 |
| 67 | metanephric epithelium development (GO:0072207) | 4.24657500 |
| 68 | peptide catabolic process (GO:0043171) | 4.24614499 |
| 69 | nephron tubule development (GO:0072080) | 4.16998200 |
| 70 | sodium-independent organic anion transport (GO:0043252) | 4.14719461 |
| 71 | fatty acid oxidation (GO:0019395) | 4.12606892 |
| 72 | carnitine metabolic process (GO:0009437) | 4.12379271 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.11450684 |
| 74 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.11081523 |
| 75 | oligosaccharide catabolic process (GO:0009313) | 4.09483270 |
| 76 | lipid oxidation (GO:0034440) | 4.04846608 |
| 77 | resolution of meiotic recombination intermediates (GO:0000712) | 4.03542327 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 4.03290848 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 4.01668268 |
| 80 | response to phenylpropanoid (GO:0080184) | 4.01073679 |
| 81 | positive regulation of meiosis (GO:0045836) | 3.97093890 |
| 82 | positive regulation of glomerulus development (GO:0090193) | 3.92996950 |
| 83 | NADH metabolic process (GO:0006734) | 3.87298736 |
| 84 | cardiovascular system development (GO:0072358) | 3.86586736 |
| 85 | glutathione metabolic process (GO:0006749) | 3.85657372 |
| 86 | regulation of meiosis I (GO:0060631) | 3.85136763 |
| 87 | glutamate metabolic process (GO:0006536) | 3.84010379 |
| 88 | cellular amino acid catabolic process (GO:0009063) | 3.83580769 |
| 89 | response to parathyroid hormone (GO:0071107) | 3.80968005 |
| 90 | vitamin transport (GO:0051180) | 3.78263120 |
| 91 | beta-amyloid metabolic process (GO:0050435) | 3.76645487 |
| 92 | response to growth hormone (GO:0060416) | 3.76590311 |
| 93 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.70594014 |
| 94 | renal tubule development (GO:0061326) | 3.69989954 |
| 95 | alpha-amino acid catabolic process (GO:1901606) | 3.68038541 |
| 96 | fatty acid catabolic process (GO:0009062) | 3.67691875 |
| 97 | positive regulation of meiotic cell cycle (GO:0051446) | 3.65525938 |
| 98 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.60567387 |
| 99 | indole-containing compound metabolic process (GO:0042430) | 3.60365934 |
| 100 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.58822567 |
| 101 | sulfur amino acid catabolic process (GO:0000098) | 3.58434548 |
| 102 | L-methionine salvage (GO:0071267) | 3.57368920 |
| 103 | L-methionine biosynthetic process (GO:0071265) | 3.57368920 |
| 104 | amino acid salvage (GO:0043102) | 3.57368920 |
| 105 | glutathione derivative metabolic process (GO:1901685) | 3.56212068 |
| 106 | glutathione derivative biosynthetic process (GO:1901687) | 3.56212068 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 3.56163848 |
| 108 | drug metabolic process (GO:0017144) | 3.54619381 |
| 109 | ketone body metabolic process (GO:1902224) | 3.53800252 |
| 110 | fatty acid elongation (GO:0030497) | 3.52088258 |
| 111 | pattern specification involved in kidney development (GO:0061004) | 3.50334191 |
| 112 | organic acid catabolic process (GO:0016054) | 3.49760557 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.49760557 |
| 114 | nephron tubule morphogenesis (GO:0072078) | 3.48112790 |
| 115 | nephron epithelium morphogenesis (GO:0072088) | 3.48112790 |
| 116 | cell differentiation involved in metanephros development (GO:0072202) | 3.46841048 |
| 117 | monocarboxylic acid catabolic process (GO:0072329) | 3.45102370 |
| 118 | retinal cone cell development (GO:0046549) | 3.44501414 |
| 119 | gamma-aminobutyric acid transport (GO:0015812) | 3.41897759 |
| 120 | nephron epithelium development (GO:0072009) | 3.35987562 |
| 121 | flavonoid metabolic process (GO:0009812) | 3.35471120 |
| 122 | tricarboxylic acid cycle (GO:0006099) | 3.35169599 |
| 123 | benzene-containing compound metabolic process (GO:0042537) | 3.34426306 |
| 124 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.34216096 |
| 125 | glucuronate metabolic process (GO:0019585) | 3.33848645 |
| 126 | uronic acid metabolic process (GO:0006063) | 3.33848645 |
| 127 | succinate metabolic process (GO:0006105) | 3.32991915 |
| 128 | dicarboxylic acid metabolic process (GO:0043648) | 3.31984320 |
| 129 | behavioral response to nicotine (GO:0035095) | 3.31314845 |
| 130 | regulation of stem cell maintenance (GO:2000036) | 3.30218097 |
| 131 | positive regulation of immune response to tumor cell (GO:0002839) | 3.29513461 |
| 132 | regulation of immune response to tumor cell (GO:0002837) | 3.29513461 |
| 133 | regulation of response to tumor cell (GO:0002834) | 3.29513461 |
| 134 | positive regulation of response to tumor cell (GO:0002836) | 3.29513461 |
| 135 | inositol metabolic process (GO:0006020) | 3.28975449 |
| 136 | regulation of hippo signaling (GO:0035330) | 3.24591776 |
| 137 | bone trabecula formation (GO:0060346) | 3.24210374 |
| 138 | synaptonemal complex assembly (GO:0007130) | 3.20463253 |
| 139 | energy homeostasis (GO:0097009) | 3.19139987 |
| 140 | C4-dicarboxylate transport (GO:0015740) | 3.18871114 |
| 141 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.11522317 |
| 142 | artery smooth muscle contraction (GO:0014824) | 3.09484354 |
| 143 | dopamine transport (GO:0015872) | 3.09007632 |
| 144 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.06461701 |
| 145 | negative regulation of kidney development (GO:0090185) | 3.04683861 |
| 146 | synaptonemal complex organization (GO:0070193) | 3.04608133 |
| 147 | metanephric mesenchyme development (GO:0072075) | 3.02844930 |
| 148 | cellular response to ammonium ion (GO:0071242) | 3.01972830 |
| 149 | response to water (GO:0009415) | 2.96480767 |
| 150 | tonic smooth muscle contraction (GO:0014820) | 2.95820661 |
| 151 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.94379902 |
| 152 | S-adenosylmethionine metabolic process (GO:0046500) | 2.92233980 |
| 153 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.90753284 |
| 154 | embryonic epithelial tube formation (GO:0001838) | 2.88253666 |
| 155 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.88117327 |
| 156 | fatty acid transmembrane transport (GO:1902001) | 2.83387139 |
| 157 | inositol phosphate-mediated signaling (GO:0048016) | 2.80453613 |
| 158 | reciprocal meiotic recombination (GO:0007131) | 2.80104683 |
| 159 | reciprocal DNA recombination (GO:0035825) | 2.80104683 |
| 160 | epithelial tube formation (GO:0072175) | 2.74060455 |
| 161 | negative regulation of telomere maintenance (GO:0032205) | 2.73704550 |
| 162 | piRNA metabolic process (GO:0034587) | 2.73200987 |
| 163 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.72766332 |
| 164 | urogenital system development (GO:0001655) | 2.68400045 |
| 165 | urate metabolic process (GO:0046415) | 11.1375871 |
| 166 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.8048453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.41815982 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66802549 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.39017954 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.59655824 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30077164 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89951290 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.68663489 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.97211260 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.96620187 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.90891396 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.87756557 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69464243 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.66888135 |
| 14 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.54809059 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.46914849 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.42989936 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.33457980 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.33387258 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.27453646 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.25394904 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.21636124 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.18103883 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15710787 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08599839 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.06984056 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03515835 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02798149 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.98259884 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.96354548 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95874969 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89896570 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88098115 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83013140 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.81341363 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.75726364 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73221652 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71507424 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70849387 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.70602134 |
| 40 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.64131833 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63410939 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.62151712 |
| 43 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.62151712 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.60675574 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.58442486 |
| 46 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55363199 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54814678 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54221266 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53603056 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.51282880 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51221820 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51112342 |
| 53 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.48151811 |
| 54 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.47722758 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47056475 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45654844 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45634778 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.45066977 |
| 59 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44009110 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43705328 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43679839 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43563532 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43563532 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42657287 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41292957 |
| 66 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41274095 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41246511 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39450379 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39244311 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37786090 |
| 71 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37637999 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36696253 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36217769 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35032224 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34491268 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34092932 |
| 77 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34043568 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32655136 |
| 79 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30997442 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30332473 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28215159 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26373407 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26210117 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25141680 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24860911 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24386675 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22661868 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21484098 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21358705 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21131669 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20998003 |
| 92 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.20609998 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20535420 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19739016 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19093909 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18837938 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18440988 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17406514 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16918670 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16918670 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 1.16714258 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16692866 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15567063 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15181504 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14845341 |
| 106 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.14238638 |
| 107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13815946 |
| 108 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.13339306 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13318129 |
| 110 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10889398 |
| 111 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10329417 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10297135 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09538792 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09491079 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09360377 |
| 116 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09098176 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08999093 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07688448 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07688448 |
| 120 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06195602 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04813207 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03293926 |
| 123 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02423581 |
| 124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02391819 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02045826 |
| 126 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01992066 |
| 127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01904476 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01845145 |
| 129 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01064966 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00818523 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00174489 |
| 132 | JUN_21703547_ChIP-Seq_K562_Human | 1.00098688 |
| 133 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99924382 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99828821 |
| 135 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.99462321 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98933394 |
| 137 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98669422 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97768897 |
| 139 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97593860 |
| 140 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.96794413 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96302897 |
| 142 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95226475 |
| 143 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95000730 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93382942 |
| 145 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91918030 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90194700 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89379643 |
| 148 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87411454 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86728053 |
| 150 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86639622 |
| 151 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86591532 |
| 152 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.86500562 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85876184 |
| 154 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84790312 |
| 155 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84108390 |
| 156 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83958230 |
| 157 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82330171 |
| 158 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.81298250 |
| 159 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80871327 |
| 160 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80337446 |
| 161 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.79065212 |
| 162 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78876866 |
| 163 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78573046 |
| 164 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78228901 |
| 165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76714931 |
| 166 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76596746 |
| 167 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.75835567 |
| 168 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.73593112 |
| 169 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.71857974 |
| 170 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70567508 |
| 171 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70476435 |
| 172 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.70344487 |
| 173 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70137947 |
| 174 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.70007743 |
| 175 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69573094 |
| 176 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68631510 |
| 177 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67977829 |
| 178 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67929403 |
| 179 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.67632092 |
| 180 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66823750 |
| 181 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66652790 |
| 182 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66625305 |
| 183 | P68_20966046_ChIP-Seq_HELA_Human | 0.66540001 |
| 184 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66195175 |
| 185 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.66040949 |
| 186 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65558810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.66568561 |
| 2 | MP0004043_abnormal_pH_regulation | 6.22492960 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.10349553 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 5.05143901 |
| 5 | MP0005332_abnormal_amino_acid | 4.97498540 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.26694030 |
| 7 | MP0009643_abnormal_urine_homeostasis | 3.96176700 |
| 8 | MP0003195_calcinosis | 3.79702958 |
| 9 | MP0001765_abnormal_ion_homeostasis | 3.78452973 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.13700344 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.03552719 |
| 12 | MP0001756_abnormal_urination | 2.99886544 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.92326501 |
| 14 | MP0003878_abnormal_ear_physiology | 2.92326501 |
| 15 | MP0002136_abnormal_kidney_physiology | 2.91484616 |
| 16 | MP0001958_emphysema | 2.70861770 |
| 17 | MP0003252_abnormal_bile_duct | 2.51835683 |
| 18 | MP0005365_abnormal_bile_salt | 2.34501552 |
| 19 | MP0008872_abnormal_physiological_respon | 2.28990911 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.26526539 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.24188610 |
| 22 | MP0003186_abnormal_redox_activity | 1.83550647 |
| 23 | MP0003045_fibrosis | 1.67074291 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66716848 |
| 25 | MP0004885_abnormal_endolymph | 1.65122289 |
| 26 | MP0000538_abnormal_urinary_bladder | 1.64667974 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.62802228 |
| 28 | MP0008961_abnormal_basal_metabolism | 1.62485075 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.53778624 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.52298394 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.47112853 |
| 32 | MP0002928_abnormal_bile_duct | 1.43954467 |
| 33 | MP0002160_abnormal_reproductive_system | 1.43133402 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.41830680 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.41473221 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.32905695 |
| 37 | MP0001270_distended_abdomen | 1.31443111 |
| 38 | MP0003718_maternal_effect | 1.30670955 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.27307141 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.26540403 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.26268045 |
| 42 | MP0005451_abnormal_body_composition | 1.23130688 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.22576967 |
| 44 | MP0002168_other_aberrant_phenotype | 1.22344729 |
| 45 | MP0005670_abnormal_white_adipose | 1.15406904 |
| 46 | MP0000230_abnormal_systemic_arterial | 1.13175979 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.11623785 |
| 48 | MP0001919_abnormal_reproductive_system | 1.09861815 |
| 49 | MP0004147_increased_porphyrin_level | 1.07847547 |
| 50 | MP0002135_abnormal_kidney_morphology | 1.06655649 |
| 51 | MP0005535_abnormal_body_temperature | 1.06287203 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.05016740 |
| 53 | MP0002089_abnormal_postnatal_growth/wei | 1.04501583 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.02818525 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.01768186 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.00750130 |
| 57 | MP0005389_reproductive_system_phenotype | 0.99829665 |
| 58 | MP0001666_abnormal_nutrient_absorption | 0.99416095 |
| 59 | MP0001664_abnormal_digestion | 0.99126118 |
| 60 | MP0002736_abnormal_nociception_after | 0.98055684 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 0.97542255 |
| 62 | MP0001968_abnormal_touch/_nociception | 0.97006039 |
| 63 | MP0003172_abnormal_lysosome_physiology | 0.96458193 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 0.96117310 |
| 65 | MP0001764_abnormal_homeostasis | 0.95920007 |
| 66 | MP0003136_yellow_coat_color | 0.95609407 |
| 67 | MP0003283_abnormal_digestive_organ | 0.93196157 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.90819000 |
| 69 | MP0000427_abnormal_hair_cycle | 0.89493756 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 0.89199731 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.89034860 |
| 72 | MP0005410_abnormal_fertilization | 0.85443774 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.82551659 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.81209712 |
| 75 | MP0004233_abnormal_muscle_weight | 0.80996164 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.78931822 |
| 77 | MP0003646_muscle_fatigue | 0.78287550 |
| 78 | MP0001440_abnormal_grooming_behavior | 0.76289892 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.75634748 |
| 80 | MP0001661_extended_life_span | 0.75559184 |
| 81 | MP0004130_abnormal_muscle_cell | 0.75409995 |
| 82 | MP0000747_muscle_weakness | 0.74920584 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.74524278 |
| 84 | MP0002272_abnormal_nervous_system | 0.74257047 |
| 85 | MP0009745_abnormal_behavioral_response | 0.70655305 |
| 86 | MP0000049_abnormal_middle_ear | 0.70181356 |
| 87 | MP0002796_impaired_skin_barrier | 0.69613008 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.69146494 |
| 89 | MP0009764_decreased_sensitivity_to | 0.67134749 |
| 90 | MP0000371_diluted_coat_color | 0.65597501 |
| 91 | MP0001486_abnormal_startle_reflex | 0.64791863 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.64592654 |
| 93 | MP0000609_abnormal_liver_physiology | 0.64522557 |
| 94 | MP0005647_abnormal_sex_gland | 0.63544247 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.63200379 |
| 96 | MP0005395_other_phenotype | 0.61332727 |
| 97 | MP0003879_abnormal_hair_cell | 0.61020829 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.56794147 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.55785728 |
| 100 | MP0002115_abnormal_skeleton_extremities | 0.54260601 |
| 101 | MP0000598_abnormal_liver_morphology | 0.54219403 |
| 102 | MP0008469_abnormal_protein_level | 0.54020171 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.53969464 |
| 104 | MP0003329_amyloid_beta_deposits | 0.53533634 |
| 105 | MP0000026_abnormal_inner_ear | 0.53351111 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.53302578 |
| 107 | MP0003959_abnormal_lean_body | 0.53195297 |
| 108 | MP0005501_abnormal_skin_physiology | 0.53075219 |
| 109 | MP0001324_abnormal_eye_pigmentation | 0.52944559 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.52739757 |
| 111 | MP0005195_abnormal_posterior_eye | 0.51830556 |
| 112 | MP0005408_hypopigmentation | 0.50465434 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.48762140 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.48031867 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.47526345 |
| 116 | MP0005503_abnormal_tendon_morphology | 0.47144057 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.47079224 |
| 118 | MP0003795_abnormal_bone_structure | 0.46820666 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.46773637 |
| 120 | MP0002210_abnormal_sex_determination | 0.46744104 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.46255487 |
| 122 | MP0004742_abnormal_vestibular_system | 0.45330696 |
| 123 | MP0003953_abnormal_hormone_level | 0.45133969 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.44756655 |
| 125 | MP0003632_abnormal_nervous_system | 0.44751920 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.44554233 |
| 127 | MP0005266_abnormal_metabolism | 0.44404771 |
| 128 | MP0005165_increased_susceptibility_to | 0.43052364 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.42616666 |
| 130 | MP0003698_abnormal_male_reproductive | 0.42401287 |
| 131 | MP0001970_abnormal_pain_threshold | 0.42221516 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.41251555 |
| 133 | MP0000163_abnormal_cartilage_morphology | 0.40946384 |
| 134 | MP0004272_abnormal_basement_membrane | 0.38895830 |
| 135 | MP0002098_abnormal_vibrissa_morphology | 0.37576650 |
| 136 | MP0009672_abnormal_birth_weight | 0.36348782 |
| 137 | MP0004858_abnormal_nervous_system | 0.35786070 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.33733156 |
| 139 | MP0003724_increased_susceptibility_to | 0.33307280 |
| 140 | MP0001663_abnormal_digestive_system | 0.32944577 |
| 141 | MP0004484_altered_response_of | 0.32234175 |
| 142 | MP0001963_abnormal_hearing_physiology | 0.30968127 |
| 143 | MP0001731_abnormal_postnatal_growth | 0.30646690 |
| 144 | MP0001177_atelectasis | 0.29988872 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.29851923 |
| 146 | MP0005083_abnormal_biliary_tract | 0.28489799 |
| 147 | MP0009780_abnormal_chondrocyte_physiolo | 0.28270628 |
| 148 | MP0002971_abnormal_brown_adipose | 0.27303186 |
| 149 | MP0002113_abnormal_skeleton_development | 0.25283718 |
| 150 | MP0000534_abnormal_ureter_morphology | 0.24011721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.40220406 |
| 2 | Gout (HP:0001997) | 6.98480508 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.97413731 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.95962275 |
| 5 | Hypomagnesemia (HP:0002917) | 6.66350784 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 6.45555195 |
| 7 | Polyuria (HP:0000103) | 6.38053493 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.02677727 |
| 9 | Abnormal urine output (HP:0012590) | 5.99580050 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.78011817 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.64733755 |
| 12 | Proximal tubulopathy (HP:0000114) | 5.58654453 |
| 13 | Polydipsia (HP:0001959) | 5.16293574 |
| 14 | Abnormal drinking behavior (HP:0030082) | 5.16293574 |
| 15 | Hyperuricemia (HP:0002149) | 5.03180392 |
| 16 | Increased purine levels (HP:0004368) | 5.03180392 |
| 17 | Hyperglycinuria (HP:0003108) | 4.68159511 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.64606494 |
| 19 | Abnormality of renin-angiotensin system (HP:0000847) | 4.59681666 |
| 20 | Alkalosis (HP:0001948) | 4.59227574 |
| 21 | Tetany (HP:0001281) | 4.56860228 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 4.56838034 |
| 23 | Renal salt wasting (HP:0000127) | 4.50685439 |
| 24 | Hyperaldosteronism (HP:0000859) | 4.43349219 |
| 25 | Generalized aminoaciduria (HP:0002909) | 4.34203349 |
| 26 | Hypercalciuria (HP:0002150) | 4.07677354 |
| 27 | Unilateral renal agenesis (HP:0000122) | 3.96146497 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.87699209 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87699209 |
| 30 | Glycosuria (HP:0003076) | 3.81987266 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.81987266 |
| 32 | Ketoacidosis (HP:0001993) | 3.77189611 |
| 33 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.67693884 |
| 34 | Hypoplasia of the fovea (HP:0007750) | 3.67693884 |
| 35 | Renal tubular acidosis (HP:0001947) | 3.59707970 |
| 36 | Hypokalemia (HP:0002900) | 3.51953981 |
| 37 | Hyperphosphaturia (HP:0003109) | 3.41532608 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34885268 |
| 39 | Ketosis (HP:0001946) | 3.34398491 |
| 40 | Delayed epiphyseal ossification (HP:0002663) | 3.27108906 |
| 41 | Abnormal urine phosphate concentration (HP:0012599) | 3.19942374 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 2.99368032 |
| 43 | Hydroxyprolinuria (HP:0003080) | 2.99368032 |
| 44 | Nephrocalcinosis (HP:0000121) | 2.98092187 |
| 45 | Abnormality of potassium homeostasis (HP:0011042) | 2.97405724 |
| 46 | Abnormality of the fovea (HP:0000493) | 2.90718773 |
| 47 | Large eyes (HP:0001090) | 2.90569975 |
| 48 | Nephrolithiasis (HP:0000787) | 2.88486292 |
| 49 | Hypophosphatemia (HP:0002148) | 2.80115653 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.77819949 |
| 51 | Vascular calcification (HP:0004934) | 2.76817692 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.76662746 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.75939327 |
| 54 | Hyperglycinemia (HP:0002154) | 2.74352448 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.73867712 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.63930741 |
| 57 | Metaphyseal cupping (HP:0003021) | 2.62798073 |
| 58 | Abnormality of macular pigmentation (HP:0008002) | 2.62226164 |
| 59 | Rickets (HP:0002748) | 2.61989657 |
| 60 | Bilateral microphthalmos (HP:0007633) | 2.56073569 |
| 61 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.54245452 |
| 62 | Widely patent fontanelles and sutures (HP:0004492) | 2.49832163 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47848172 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.47848172 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.47617437 |
| 66 | Dehydration (HP:0001944) | 2.43042783 |
| 67 | Hyperammonemia (HP:0001987) | 2.42162436 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37939921 |
| 69 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.37475022 |
| 70 | Enlarged kidneys (HP:0000105) | 2.32734484 |
| 71 | Confusion (HP:0001289) | 2.32730641 |
| 72 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.32502677 |
| 73 | Abnormality of renal resorption (HP:0011038) | 2.30971674 |
| 74 | Abnormality of the renal medulla (HP:0100957) | 2.30808205 |
| 75 | Metabolic acidosis (HP:0001942) | 2.30739903 |
| 76 | Vomiting (HP:0002013) | 2.28069401 |
| 77 | Abnormality of sodium homeostasis (HP:0010931) | 2.26215326 |
| 78 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.26104814 |
| 79 | Hyponatremia (HP:0002902) | 2.26044465 |
| 80 | Renal tubular dysfunction (HP:0000124) | 2.22499305 |
| 81 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22083587 |
| 82 | Malnutrition (HP:0004395) | 2.21042680 |
| 83 | Thin bony cortex (HP:0002753) | 2.20996963 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.17639240 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 2.13646905 |
| 86 | Pancreatic cysts (HP:0001737) | 2.12040912 |
| 87 | Abnormality of the renal cortex (HP:0011035) | 2.11038932 |
| 88 | Lethargy (HP:0001254) | 2.06276042 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04889425 |
| 90 | Generalized muscle weakness (HP:0003324) | 2.03137157 |
| 91 | Adrenal overactivity (HP:0002717) | 2.00787585 |
| 92 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.00307583 |
| 93 | Chorioretinal atrophy (HP:0000533) | 1.98641934 |
| 94 | Tubulointerstitial fibrosis (HP:0005576) | 1.97859998 |
| 95 | Fused cervical vertebrae (HP:0002949) | 1.96486721 |
| 96 | Facial shape deformation (HP:0011334) | 1.95410672 |
| 97 | Potter facies (HP:0002009) | 1.95410672 |
| 98 | Lymphangioma (HP:0100764) | 1.93689637 |
| 99 | Bicornuate uterus (HP:0000813) | 1.91243083 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 1.90370509 |
| 101 | Tubular atrophy (HP:0000092) | 1.88019948 |
| 102 | Abnormality of the costochondral junction (HP:0000919) | 1.86677849 |
| 103 | Congenital stationary night blindness (HP:0007642) | 1.86148691 |
| 104 | Metaphyseal irregularity (HP:0003025) | 1.86000319 |
| 105 | Chondrocalcinosis (HP:0000934) | 1.84988642 |
| 106 | Elevated alkaline phosphatase (HP:0003155) | 1.81228778 |
| 107 | Nausea (HP:0002018) | 1.81110057 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80868084 |
| 109 | Irritability (HP:0000737) | 1.80607641 |
| 110 | Hypoplasia of the uterus (HP:0000013) | 1.77463391 |
| 111 | Decreased circulating renin level (HP:0003351) | 1.77455515 |
| 112 | Metaphyseal dysplasia (HP:0100255) | 1.75649730 |
| 113 | Progressive inability to walk (HP:0002505) | 1.75538583 |
| 114 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74025243 |
| 115 | Abnormality of Sharpey fibers (HP:0100685) | 1.72561480 |
| 116 | Late onset (HP:0003584) | 1.70792608 |
| 117 | Abnormality of serum amino acid levels (HP:0003112) | 1.70613195 |
| 118 | Neonatal onset (HP:0003623) | 1.69120681 |
| 119 | Tachypnea (HP:0002789) | 1.69083342 |
| 120 | Abnormality of carpal bone ossification (HP:0006257) | 1.68908590 |
| 121 | Glomerulosclerosis (HP:0000096) | 1.68494338 |
| 122 | Tubulointerstitial abnormality (HP:0001969) | 1.67311707 |
| 123 | Type II lissencephaly (HP:0007260) | 1.54036039 |
| 124 | Hypotension (HP:0002615) | 1.51262046 |
| 125 | Stage 5 chronic kidney disease (HP:0003774) | 1.51196936 |
| 126 | Aplasia cutis congenita (HP:0001057) | 1.49348324 |
| 127 | Cystic liver disease (HP:0006706) | 1.49119439 |
| 128 | Inability to walk (HP:0002540) | 1.44396443 |
| 129 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.43643048 |
| 130 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.41289714 |
| 131 | 3-Methylglutaconic aciduria (HP:0003535) | 1.39912908 |
| 132 | Hypophosphatemic rickets (HP:0004912) | 1.38697170 |
| 133 | Intrahepatic cholestasis (HP:0001406) | 1.35873259 |
| 134 | Lissencephaly (HP:0001339) | 1.32296645 |
| 135 | Hypothermia (HP:0002045) | 1.29796309 |
| 136 | Mixed hearing impairment (HP:0000410) | 1.27729366 |
| 137 | Gaze-evoked nystagmus (HP:0000640) | 1.26510674 |
| 138 | Hip dysplasia (HP:0001385) | 1.25797891 |
| 139 | Congenital hepatic fibrosis (HP:0002612) | 1.24575113 |
| 140 | CNS hypomyelination (HP:0003429) | 1.24043474 |
| 141 | Decreased central vision (HP:0007663) | 1.20708135 |
| 142 | Abnormality of midbrain morphology (HP:0002418) | 1.20648130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.19160256 |
| 2 | WNK3 | 7.77209631 |
| 3 | OXSR1 | 7.23387394 |
| 4 | STK39 | 4.38918463 |
| 5 | BCKDK | 3.28212093 |
| 6 | STK38L | 2.74753852 |
| 7 | RIPK4 | 2.53545689 |
| 8 | NEK1 | 2.11735429 |
| 9 | WNK1 | 2.11450681 |
| 10 | PDK4 | 2.08789825 |
| 11 | PDK3 | 2.08789825 |
| 12 | TLK1 | 1.96905550 |
| 13 | BMPR2 | 1.94064959 |
| 14 | SGK494 | 1.83808366 |
| 15 | SGK223 | 1.83808366 |
| 16 | BMPR1B | 1.81892665 |
| 17 | SIK3 | 1.62255477 |
| 18 | ADRBK2 | 1.52675600 |
| 19 | SIK2 | 1.51134808 |
| 20 | STK38 | 1.43414493 |
| 21 | PDK2 | 1.41191878 |
| 22 | MST1R | 1.28521618 |
| 23 | MST4 | 1.21986214 |
| 24 | GRK1 | 1.14654021 |
| 25 | DAPK2 | 1.10540625 |
| 26 | FGFR4 | 1.06779021 |
| 27 | LRRK2 | 1.03558119 |
| 28 | NEK2 | 0.97560430 |
| 29 | SGK3 | 0.95542997 |
| 30 | PINK1 | 0.94700369 |
| 31 | ACVR1B | 0.92741825 |
| 32 | SGK2 | 0.92146345 |
| 33 | FLT3 | 0.91383416 |
| 34 | GRK6 | 0.89335697 |
| 35 | STK3 | 0.89021200 |
| 36 | ERBB2 | 0.88814314 |
| 37 | SIK1 | 0.84745434 |
| 38 | TRPM7 | 0.82276944 |
| 39 | EPHB1 | 0.82129892 |
| 40 | BRSK2 | 0.79580809 |
| 41 | GSK3A | 0.76063546 |
| 42 | MARK3 | 0.75692371 |
| 43 | TGFBR1 | 0.73137201 |
| 44 | BCR | 0.71410416 |
| 45 | TAOK3 | 0.71276445 |
| 46 | MAP4K2 | 0.68032068 |
| 47 | MAPKAPK3 | 0.67239406 |
| 48 | DYRK1B | 0.65131501 |
| 49 | MAP3K7 | 0.64224797 |
| 50 | PIK3CA | 0.63939580 |
| 51 | PTK2 | 0.61566123 |
| 52 | SGK1 | 0.60704879 |
| 53 | PRKCE | 0.60410117 |
| 54 | MAP3K3 | 0.58903728 |
| 55 | TXK | 0.58040736 |
| 56 | TIE1 | 0.57143278 |
| 57 | MAPKAPK5 | 0.56382975 |
| 58 | ADRBK1 | 0.56342752 |
| 59 | NUAK1 | 0.53923717 |
| 60 | TGFBR2 | 0.52953146 |
| 61 | ABL2 | 0.52458283 |
| 62 | MELK | 0.51877736 |
| 63 | PRKAA1 | 0.49362019 |
| 64 | TRIM28 | 0.48641394 |
| 65 | PAK4 | 0.48635012 |
| 66 | MAPK11 | 0.47679909 |
| 67 | PDPK1 | 0.46173155 |
| 68 | MATK | 0.45369520 |
| 69 | ERN1 | 0.44811860 |
| 70 | TRIB3 | 0.44716958 |
| 71 | MAPK13 | 0.43731833 |
| 72 | PTK6 | 0.42926108 |
| 73 | INSRR | 0.42900276 |
| 74 | PAK3 | 0.39685416 |
| 75 | CSNK1A1 | 0.39674248 |
| 76 | ZAK | 0.37417509 |
| 77 | STK10 | 0.36311762 |
| 78 | PRKCI | 0.35973739 |
| 79 | MET | 0.35931925 |
| 80 | PRKAA2 | 0.35623696 |
| 81 | RIPK1 | 0.33851943 |
| 82 | PRKD2 | 0.32738667 |
| 83 | MAP3K4 | 0.32535551 |
| 84 | FRK | 0.32271349 |
| 85 | MAP3K2 | 0.31700611 |
| 86 | PRKCZ | 0.31558491 |
| 87 | PDK1 | 0.30866139 |
| 88 | PTK2B | 0.30830043 |
| 89 | FER | 0.30799867 |
| 90 | TEC | 0.29158263 |
| 91 | MYLK | 0.28938724 |
| 92 | CAMK2A | 0.28927014 |
| 93 | STK11 | 0.28580194 |
| 94 | NME2 | 0.27428226 |
| 95 | CAMK1 | 0.26694873 |
| 96 | MAP3K9 | 0.26564180 |
| 97 | NTRK1 | 0.25690474 |
| 98 | IRAK2 | 0.24368097 |
| 99 | PRKCD | 0.23226893 |
| 100 | STK24 | 0.21203413 |
| 101 | LATS1 | 0.21172989 |
| 102 | MAPK15 | 0.21079680 |
| 103 | MAP2K6 | 0.20341837 |
| 104 | MAP3K14 | 0.20132770 |
| 105 | PRKCH | 0.19967519 |
| 106 | PRKACG | 0.19317775 |
| 107 | KIT | 0.18718691 |
| 108 | ERBB4 | 0.17962839 |
| 109 | HIPK2 | 0.17494246 |
| 110 | TAF1 | 0.16572787 |
| 111 | MINK1 | 0.16406673 |
| 112 | DYRK1A | 0.16350679 |
| 113 | GRK7 | 0.15967170 |
| 114 | AKT2 | 0.15677644 |
| 115 | NLK | 0.15257360 |
| 116 | GRK5 | 0.14867173 |
| 117 | PRKCA | 0.14309957 |
| 118 | PRKCB | 0.13597990 |
| 119 | NEK6 | 0.13090264 |
| 120 | BMX | 0.13077073 |
| 121 | JAK2 | 0.12844974 |
| 122 | IRAK3 | 0.12763914 |
| 123 | EEF2K | 0.12383606 |
| 124 | BTK | 0.11748619 |
| 125 | PIM1 | 0.11591344 |
| 126 | PRKACA | 0.11520942 |
| 127 | MAPK7 | 0.10954673 |
| 128 | MAP2K1 | 0.10894018 |
| 129 | DYRK2 | 0.10586305 |
| 130 | SCYL2 | 0.10289377 |
| 131 | EPHA4 | 0.09900324 |
| 132 | VRK2 | 0.09483410 |
| 133 | ROCK1 | 0.09143041 |
| 134 | NTRK3 | 0.08997490 |
| 135 | MAP2K7 | 0.08981366 |
| 136 | PKN1 | 0.08595280 |
| 137 | IRAK1 | 0.08467239 |
| 138 | SYK | 0.08351531 |
| 139 | MAP2K4 | 0.08152876 |
| 140 | INSR | 0.07839920 |
| 141 | MAP2K3 | 0.07498691 |
| 142 | PRKCG | 0.06462083 |
| 143 | PRKD3 | 0.05936816 |
| 144 | MAPK12 | 0.05499426 |
| 145 | PRKCQ | 0.05003049 |
| 146 | NME1 | 0.04384959 |
| 147 | SRC | 0.04213578 |
| 148 | ITK | 0.03241573 |
| 149 | MAP3K11 | 0.02916399 |
| 150 | IGF1R | 0.01660661 |
| 151 | CAMK4 | 0.01585442 |
| 152 | MTOR | 0.01552865 |
| 153 | CSK | 0.00805270 |
| 154 | NEK9 | 0.00662843 |
| 155 | PDGFRA | -0.0191824 |
| 156 | ABL1 | -0.0177388 |
| 157 | CAMK1G | -0.0135650 |
| 158 | PRKACB | -0.0115685 |
| 159 | PIK3CG | -0.0113444 |
| 160 | MAPK4 | -0.0033430 |
| 161 | RPS6KA3 | -0.0018982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.05778868 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.88194860 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.53051964 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43772952 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.35480407 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.16860385 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.11849723 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05946862 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.01692870 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66571996 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.59134405 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.52625622 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.50408859 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.46590853 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30811447 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.25625049 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18998459 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.12659491 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.10484535 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.05166553 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02470391 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.97830525 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89326847 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89226578 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82680684 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74459113 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64593442 |
| 28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.59992388 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.59834823 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.58343741 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.58185220 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57315203 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57208165 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56448329 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46771139 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32520452 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31149403 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.25735927 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22870096 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21250137 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21219591 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19189609 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.17720625 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16814732 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15621730 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11096869 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08159265 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07272715 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05568562 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05404355 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05397284 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05097082 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00967162 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95755068 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94468297 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93390821 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92993888 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91833859 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.91780165 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.91082253 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90518596 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89199884 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88418167 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.88280119 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85560264 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83535208 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81755125 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80079426 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77118747 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74336964 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72814878 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.72803448 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68390809 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68218885 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67904781 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67412765 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66510961 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66242199 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65628121 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65384579 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65251541 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.63880846 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63570242 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.63023009 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61255738 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59894579 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59497810 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56991937 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53895573 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53848345 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53366405 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53180492 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53177014 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52273711 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44276026 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44213102 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41216628 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40302227 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39112313 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34827298 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33937335 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32435055 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32225105 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31204139 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30020438 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27819334 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26926530 |
| 108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26316005 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26174536 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26046642 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.25269606 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24518006 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24177916 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23910104 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.23214775 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22413380 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.21484805 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21041985 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19320569 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15623310 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14623388 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.12853405 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10188191 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.10069798 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.07930601 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06790218 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.06153919 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.03896866 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.03189083 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01388284 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00919862 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.00745194 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.1015512 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | -0.0896286 |
| 135 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0815933 |
| 136 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0475099 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0462404 |
| 138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0409061 |

